Showing results (191-200 of 333) with videos related to
Sort By:
Pageof 34
Journal of Endocrinological Investigation|April 1, 2004
Slow growth of benign thyroid nodules after menopause: no need for long-term thyroxine suppressive therapy in post-menopausal womenG Costante, U Crocetti, E Schifino, et al.The Journal of Clinical Endocrinology and Metabolism|May 1, 1996
Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomasM Derwahl, C Hamacher, D Russo, et al.Cancer|February 19, 1999
Functional insulin receptors are overexpressed in thyroid tumors: is this an early event in thyroid tumorigenesis?L Frittitta, L Sciacca, R Catalfamo, et al.The Journal of Clinical Endocrinology and Metabolism|March 1, 1997
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinomaD Russo, S Tumino, F Arturi, et al.Journal of Endocrinological Investigation|April 21, 2001
ApeI/Ref-I expression and cellular localization in human thyroid carcinoma cell linesD Russo, F Arturi, S Bulotta, et al.The Journal of Clinical Endocrinology and Metabolism|August 18, 2000
Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomasL Persani, A Lania, L Alberti, et al.European Journal of Endocrinology|May 7, 1999
Iodide symporter gene expression in normal and transformed rat thyroid cellsF Trapasso, R Iuliano, E Chiefari, et al.European Thyroid Journal|May 1, 2014
2012 European thyroid association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutationsR Paschke, M Niedziela, B Vaidya, et al.Clinical and Experimental Immunology|July 15, 1999
Rarity of autoantibodies to a major autoantigen, thyroid peroxidase, that interact with denatured antigen or with epitopes outside the immunodominant regionJ Guo, Y Wang, J C Jaume, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2001
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trialT J Littlewood, E Bajetta, J W Nortier, et al.Pageof 34